title: [The effect of Helicobacter pylori eradication on chronic gastritis].
abstract: Helicobacter pylori (H. pylori) is a major pathogen of chronic atrophic gastritis, intestinal metaplasia, and gastric cancer. Atrophic gastritis and intestinal metaplasia are recognized as precancerous lesion of gastric cancer. Many studies reported that H. pylori eradication had the preventive effect of gastric cancer. Moreover many studies mentioned the improvement of gastric atrophy and/or intestinal metaplasia. Two meta-analysis indicated the improvement of atrophic gastritis but not of intestinal metaplasia. In our study, intestinal metaplasia improved at lesser curvature of the corpus six years after eradication. H. pylori eradication has benefit for gastric cancer prevention provably due to improvement of the precancerous lesion such as atrophic gastritis and intestinal metaplasia. Especially, H. pylori eradication before the appearance of atrophy and intestinal metaplasia has been considered to be effective in inhibiting the development of gastric cancer. Therefore, improvement or elimination of chronic gastritis with H. pylori eradication might have possibility of gastric cancer inhibition.
authors: Department of Gastroenterology, Faculty of Medicine, Oita University.
authors: Masaaki
authors: M
authors: Kodama
authors: Kazunari
authors: K
authors: Murakami
authors: Tadayoshi
authors: T
authors: Okimoto
authors: Toshio
authors: T
authors: Fujioka
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D060740:Disease Eradication; D005756:Gastritis / Q000188:drug therapy / Q000209:etiology*; D016481:Helicobacter Infections / Q000188:drug therapy / Q000517:prevention & control*; D016480:Helicobacter pylori; D006801:Humans; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000900:Anti-Bacterial Agents